Germany· DE-A57-b922d9fd4f41fe3d
Celluvisc
A carmellose product containing carmellose sodium, registered in Germany by Abbvie Deutschland Gmbh & Co. Kg. The same ATC class is registered in 3 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Carmellose is registered in 3 of 19 countries.
Countries holding a registration under ATC S01XC08 (carmellose), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 1 of them publish a price we can compare per daily dose
Carmellose · ATC S01XC08
3 / 19 countries
- Franceprice
- Germany
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Carmellose Sodium
- Manufacturer
- Abbvie Deutschland Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- S01XC08
- ATC class
- Carmellose
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carmellose in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAaqEye Carmellose 0.5% eye dropsEssential-Healthcare Ltd
- SpainACUVISC 5 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSISTiedra Farmaceutica S.L.
- United StatesDRMITSUI HYDROCOLLOID WOUNDYIYANGYUAN LIFE SCIENCES (HONG KONG) CO., LIMITED
- IrelandCelluvisc 0.5 % w/v eye drops solution, unit doseAbbVie Limited
- SwitzerlandCellufluid
- CzechiaCELLUFLUIDAbbVie s.r.o., Praha
- NetherlandsCellufluid 0,5%, oogdruppels, oplossing, unit dose ampul, 5 mg/mlAbbVie B.V.
- FranceCELLUVISC 4 mg/0,4 ml, collyre en récipient unidoseABBVIE
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Czechia · Cellufluid
- Denmark · Celluvisc
- Spain · Carmelosa Qualigen, Carmelosa Stada
- Finland · Celluvisc
- France · Celluvisc
- United Kingdom (Northern Ireland) · Celluvisc
- Greece · Refresh Plus
- Ireland · Celluvisc
- Italy · Celluvisc
- Netherlands · Cellufluid, Celluvisc
- Portugal · Celluvisc
- Sweden · Cellufluid, Celluvisc
- Slovakia · Cellufluid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95dd7e85-47f5-4b88-a725-938982d5390b GET /v1/drugs/95dd7e85-47f5-4b88-a725-938982d5390b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Carmellose Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about carmellose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.